[New post] Esperion (ESPR) Beats on Q3 Earnings, Lowers Expense Guidance

Editorial Team posted: "Esperion Therapeutics (ESPR) reports solid third-quarter results, beating estimates for earnings and sales. However, the stock declines in pre-market trading. Find out more at https://ift.tt/3mD6Ddi via Entrepreneur.com" New post on Technology & Business News Esperion (ESPR) Beats on Q3 Earnings, Lowers Expense Guidance by Editorial Team Esperion Therapeutics (ESPR) reports solid third-quarter results, beating estimates for earnings and sales. However, the stock declines in pre-market trading. Find out more at https://ift.tt/3mD6Ddi via Entrepreneur.com Read more of this post This free site is ad-supported. Learn more ​ Editorial Team | November 2, 2021 at 11:11 am | Tags: Entrepreneur | Categories: Business | URL: https://wp.me/pcbvJV-bs9 Like Unsubscribe to no longer receive posts from Technology & Business News. Change your email settings at Manage Subscriptions. Trouble clicking? Copy and paste this URL into your browser: https://technologyandbusinessnews.wordpress.com/2021/11/02/esperion-espr-beats-on-q3-earnings-lowers-expense-guidance/ Thanks for flying with WordPress.com